Bioxyne enters Central American markets with pastille supply deal by Steve Jones December 12, 2025December 12, 2025 Breathe Life Sciences (BLS) will supply pastilles to two Central American countries in a deal it […]
News in brief: Legalise Cannabis ramps up criticism of Victorian government; MCA launches desktop guide for clinicians; Bioxyne secures A$1.7m for UK GMP facility by Adam Sheldon November 17, 2025February 21, 2026
Breathe Life Sciences launches Curaleaf medical inhalation device by Adam Sheldon November 3, 2025November 3, 2025
Record revenue for Bioxyne but cash deficit rises after flower investment by Steve Jones October 30, 2025November 3, 2025
Cannabis executive salaries: who earned what in FY25 by Adam Sheldon October 22, 2025October 22, 2025
‘It’s super exciting’ – Breathe Life Sciences secures ARTG listings for Dr Watson range by Adam Sheldon October 9, 2025October 13, 2025
Bioxyne stays on course to hit A$25m revenue guidance despite Q3 fall by Steve Jones April 28, 2025April 28, 2025
Bioxyne upgrades revenue forecast on back of record Q2 by Martin Lane January 24, 2025January 29, 2025
Bioxyne sees sharp revenue growth as shares jump after strong quarter by Steve Jones October 17, 2024February 25, 2025
